Phase 2 biotech developing an inhibitor therapy for difficult to treat cancers.
Industry: Health Care
Latest Trade: ()
First Day Return:
Return from IPO:
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 05/24/2024 |
Offer Price | |
Price Range $8.00 - $10.00 | |
Offer Shares (mm) | 3.0 |
Deal Size ($mm) | $27 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | |
Offer Price | |
Price Range $8.00 - $10.00 | |
Offer Shares (mm) | 3.0 |
Deal Size ($mm) | $27 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
Underwriters |
---|
Titan Partners |
Newbridge Securities |
Company Data | |
---|---|
Headquarters | Fort Worth, TX, United States |
Founded | 2015 |
Employees | 15 |
Website www.actuatetherapeutics.com |